About

Dec 14-15, 2022    Singapore city, Singapore

International Conference on

International Conference on Biosimilars and Generic Drugs

Longdom Conferences provide the platform to speakers and offer delegates the opportunity to share their ideas and network. We are pleased to welcome you to attend and associate with us at International Conference on Biosimilars Biologics on November 07-08, 2022 in Singapore city, Singapore.

Biosimilars 2022 mainly focuses on the theme “International Conference on Biosimilars & Biologics”. Guided by a line-up of expert speakers, researchers, doctors, students, professors and all the interested people in Biosimilars &Biologics  from all over the world for our Biosimilars 2022 to ensure that public receives the best possible care and can look forward to a bright future.

Biosimilars 2022, foresee over 200 participants from 7 continents with revolutionary subjects, discussions, and expositions. This will be excellent viability for the researchers, students and the delegates from universities and Institutes to intermingle with the world-class scientists, speakers, technicians, technical practitioners and industry professionals working in the field of Biosimilars and Biologics

Scientific Sessions:

Track 1: Biosimilars: 

Biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Within the European Union, biosimilars are approved according to the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are officially approved versions of original "innovator" products and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences

Track 2 - Biologics

 A biologic drug (biologics) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs include a wide variety of products derived from human, animal, or microorganisms by using biotechnology. Biologics are powerful medications that can be made of tiny components like sugars, proteins, or DNA or can be whole cells or tissues. These drugs also come from all sorts of living sources — mammals, birds, insects, plants, and even bacteria.

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences

Track 3: Successful biosimilar case studies :

As physician and payer confidence in the use of biosimilars grows, US and European companies are having to rethink their go-to-market commercial strategies. Price is no longer the only driver and a hybrid approach is needed to forge new commercialisation strategies and partnerships. But what are the key reimbursement, physician education and regulatory obstacles that developers must take into account                                                

  1. Humira biosimilars facing a litigious battle
  2. Biosimilar insulin–is it a sustainable business model?
  3. Roche oncology strategy–biosimilars versus next generation products
  4. Roche's RA franchise–is there room for tocilizumab biosimilars?
  5. Pegfilgrastim biosimilars provide a 33% discount and rely on a branded launch strategy

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences

Track 4: Biosimilars in Oncology

FDA-approved biosimilars can be used to treat breast cancer, stomach cancer, colorectal cancer, and other cancers. They can also be used to treat side effects of cancer treatments, such as low white blood cell counts that increase the risk of infections.Biosimilars are potentially cheaper versions of other drugs that are being developed as treatments for cancer and other diseases. However, it is important to note that biosimilars are not defined by their cost alone, and in some cases, they may not be much cheaper than other drugs. Here, find out what biosimilars are, how they can be used to treat cancer, and how they can help lower the costs of cancer care.

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences

Track 5:Analytical Strategies  Biologics  Biosimilars : 

Management of cGMP facility calls for a strict monitoring all factors including analytical strategies, formulation procedures, packaging etc. For biologic products establishing comparability and interchangeability is a big hurdle. For this purpose employment of suitable analytical approach, bioassay, protein analysis, potency testing, safety assurances are highly important. LC/MS analysis for biologic products, characterization of biologics, peptide mapping, Isoelectric Focusing and Capillary Isoelectric Focusing, SDS-PAGE, Thermal Analysis, Particulate Matter Analysis, Thermogravimetric Analysis are some methods commonly used for analysis of biologics and biosimilar products.

On average, facilities outsource 32% of their analytical testing/bioassays (up from 28%) meaning that close to one-third of analytical testing is estimated to be outsourced by the industry.

  1. Biosimilar multimodal techniques
  2. Biosimilar bioanalytical methods
  3. Bioassay for comparability and potency testing
  4. Biosimilar LC/MS analysis for discovery, preclinical, and clinical programs
  5. Biosimilar GMP protein analysis
  6. Biosimilar electrophoresis

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences

Track 6:Clinical trials of Biologics  Biosimilars :

Clinical Trials is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances. This is your best opportunity to reach the largest assemblage of participants from Clinical Trials community that is from academia, clinical research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries. Clinical Trials  will discuss various disciplines involved in the pre-clinical research, conduct of clinical trials; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials. It promotes better understanding by the general public about the importance of clinical trials in prevention, diagnosis and treatment of disease.

  1. Clinical trial market
  2. Genome annotation
  3. Single-nucleotide polymorphism
  4. Gene and protein expression

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences

Track 7:Regulatory Approaches for Biosimilars : 

Biosimilars are the generic version of biological. It is the new buzz word in pharmaceutical industry. Biosimilars are highly similar to licensed reference product not withstanding minor differences in clinically inactive components; also there are no clinically meaningful differences between the biologicals and the reference product in terms of safety, purity, and potency. This track includes: Licensing of  biosimilars, Biosimilars regulation, Patent issues, BLA filing for biosimilars, Biosimilars regulatory prospects of BRIC countries, a paradigm of traditional generics to Biosimilars, Biowaiver approval for Biosimilars and other aspects of Biosimilar approvals. Biosimilars 2018 will provide an excellent and global opportunity to the scientists, partners and pharma leaders from Biopharmaceutical and Biotechnology industries to innovate and to explore the strategic market for Biosimilars and Biologics with a clear picture of the regulatory approach for biosimilars and biologics.

  1. Licensing of biosimilars
  2. Biosimilars regulation
  3. BLA filing for biosimilars
  4. Regulatory prospects of BRIC countries
  5. A paradigm of traditional generics to biosimilars
  6. Biowaiver approval for Biosimilars
  7. Generic Biosimilars
  8. BLA filing for biosimilars

Biosimilar Conferences | Biologics Meetings | International Conferences | Medical Meetings | Biosimilars and Biologics  Conferences | International Biologics Conferences | International Biosimilars Conferences   

Market Analysis

After the successful completion of the Biosimilars 2021 Longdom, we are pleased to welcome you to the "International Conference on Biosimilars And Biologics." The conference is scheduled to take place on November 07-08, 2022 in the beautiful city of in Singapore city, Singapore. This Biosimilars 2022 Conference will give you exemplary experience and great insights in the field of research.

Based on product, the biomarkers market is segmented into consumables, services, and software. The consumables segment accounted for the largest share of the global biomarkers market in 2016, primarily due to the increasing use of reagent kits and assays for biomarker testing and the higher frequency of purchase of consumables. Although the price of consumables is lower than that of screening and automation instruments, consumables have a higher share in this market owing to their larger sales volume. As such, growth in the overall biomarkers market will be the most important driver for this product segment. Furthermore, the introduction of singleplex platforms, multiplex platforms, and automated ELISA systems that require assay kits is expected to aid the growth of this product segment.

 Past Conference Reports

Euro Pharma 2020 

We gratefully thank all our wonderful  speakers and delegates for making the Euro Pharma 2020  webinar successful.

International Webinar on Pharmaceutics and Drug Discovery, hosted by the Longdom Conference  was held during June 15, 2020 at GMT+1  based on the theme “Innovations and Advancements in Pharmaceutics and Drug Safety "

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

  1. Souvik Basak, Dr. B. C Roy College of Pharmacy, India
  2. Iris Valtingojer  Molecular Oncology Research Department , France
  3. Mallesh Kurakula ,  University of Memphis , USA
  4. Joshua A Eldridge ,  University of Kentucky , USA
  5. Prachi V Atre,  St.John’s University, USA

For More details visit: https://www.longdom.com/biosimilars

Pharmaceutics 2021 

We gratefully thank all our wonderful  speakers and delegates for making the Pharmaceutics 2021 webinar successful. International Webinar on Pharmaceutics and Drug Discovery, hosted by the Longdom Conference was held during February 28, 2021 at GMT+1  based on the theme “Innovations and Advancements in Pharmaceutics and Drug Discovery "

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. Maulik Patel, Pharmaceutical Formulation R&D Professional, China
  2. Shajila Siricilla, Vanderbilt University USA
  3. Muhammad Sibte Hasan Mahmood, Grand River Hospital, Canada
  4. Mallesh Kurakula ,  University of Memphis , USA
  5. Foziyah Zakir, Delhi Pharmaceutical Sciences and Research University, India

For More details visit: https://www.longdom.com/biosimilars

Pharma 2021

We gratefully thank all our wonderful  speakers and delegates for making the Pharma 2021 webinar successful. Webinar on Pharmaceutics and Drug Discovery, hosted by the Longdom Conference was held during May 31, 2021 at GMT+1  based on the theme “Innovations and Advancements in Pharmaceutics and Drug Discovery "

The conference was initiated with the honourable presence of the keynote forum. The list includes:

  1. Pradeep Deshmukh, Pacific Toxicology Consulting, Pune, India
  2. Iris Valtingojer  Molecular Oncology Research Department , France
  3. Muhammad Sibte Hasan Mahmood, Grand River Hospital, Canada
  4. Souvik Basak, Dr. B. C Roy College of Pharmacy, India
  5.  Foziyah Zahir, Delhi Pharmaceutical Sciences and Research University, India

For More details visit: https://www.longdom.com/biosimilars

Drug Discovery 2020

We gratefully thank all our wonderful  speakers and delegates for making the Drug Discovery 2020 webinar successful. “Webinar on Drug Discovery”, hosted by the Longdom Conferences was held during April 30, 2020 at London, UK based on the theme “Current and Future Trends in Drug Discovery"

The Webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Amrik Basran, Avacta Lifesciences. United Kingdom
  2. Madhu Gupta , Delhi Pharmaceutical Sciences & Research University, India       
  3. AliciaWu Mingshu, Guangzhou Medical Cancer Centre,  China
  4. Rashid Mahmood, Surge Laboratories Private Limited,Pakistan.
  5. Wayne J. M. Karim, Yokohama-city University, Japan

For More details visit: https://www.longdom.com/biosimilars

Pharmacology 2020

We gratefully thank all our wonderful  speakers and delegates for making the Pharmacology 2020 webinar successful. “Webinar on  Pharmacology”, hosted by the Longdom Conferences was held during May 31, 2020 at London, UK based on the theme “Innovations And Advancements in Pharmaceutics"

The Webinar was initiated with the honourable presence of the keynote forum. The list includes:

  1. Wasfi Alazzam, Avacta Lifesciences, United Kingdom
  2. Anwar  Khan ,Luton & Dunstable University Hospital, Luton UK
  3. Foziyah Zakir, Delhi Pharmaceutical Sciences and Research University (DPSRU), India
  4. Rashid Mahmood, Surge Laboratories Private Limited,Pakistan.
  5. Wayne J. M. Karim, Yokohama-city University, Japan

With the grand success of Euro Pharma 2020, Longdom Conferences  is proud to announce the " 1st International Conference Biosimilars and Biologics"  to be held October 22-23, 2021at Zurich, Switzerland

For More details visit: https://www.longdom.com/biosimilars

  [email protected]
  [email protected]
  [email protected]
Speakers Interview